Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery
Article
Gilbert, Mark R, Kuhn, John, Lamborn, Kathleen R et al. (2012). Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery
. JOURNAL OF NEURO-ONCOLOGY, 106(1), 147-153. 10.1007/s11060-011-0650-1
Gilbert, Mark R, Kuhn, John, Lamborn, Kathleen R et al. (2012). Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery
. JOURNAL OF NEURO-ONCOLOGY, 106(1), 147-153. 10.1007/s11060-011-0650-1
Gilbert, Mark R; Kuhn, John; Lamborn, Kathleen R; Lieberman, Frank; Wen, Patrick Y; Mehta, Minesh; Cloughesy, Timothy; Lassman, Andrew B; DeAngelis, Lisa M; Chang, Susan; Prados, Michael